The RELENT Project
The RELENT Project

Work package 1 - Identification of common pathways that influence disease outcome and response to treatment and infection

Leader
undefinedProf. Renate Kain, M.D., Ph.D., Medical University Vienna

 

We will adopt two approaches, the genomic approach responsible for identifying the FOXO3 pathway; and a bottom up approach that has identified de-regulation of autophagy as a prime candidate. The work performed will include the analysis of pathways and their genomic background that influence the intensity and persistence of severe autoimmune and inflammatory diseases. It will characterize the mechanisms through which these operate in cellular models derived from patients with autoimmune disorders segregated by sex and age. The pathway analysis will validate results from undefinedWP02 on discovery of proteomic markers of disease activity or clinical outcome in patients with immune-mediated disease and the results will inform experiments executed in undefinedWP03 on ageing.

 

Description of the tasks

WP01 will build up on undefinedPartner UCAM’s expertise in identifying genomic pathways that influence the intensity and persistence of severe autoimmune and inflammatory diseases, and on characterizing molecular mechanisms responsible. Thus, a polymorphism in the FOXO3 promoter was found that affected transcription and had a powerful influence on the outcome of Crohn’s Disease. Subset analysis of genome-wide association study (GWAS) data has the potential to identify genetic variants associated with disease outcome rather than presentation. We will apply the same strategy to ANCA-associated vasculitis. This disease has been carefully selected to maximize the opportunity for discovering new genetic polymorphisms that influence disease outcome and of characterizing their effects. To facilitate this, we will exploit undefinedPartner Phenocell’s novel and exceptionally efficient ways of generating induced pluripotent stem cells (iPSCs) to create a panel of cell lines from healthy individuals of the appropriate genotype and from patients with extreme (severe/mild) disease phenotypes. The group will use macrophages and dendritic cells differentiated from these iPSCs to extend the analysis of the FOXO3 polymorphism to autophagy, a cellular pathway it controls, and related genes. This will be done using state of the art techniques optimized by undefinedPartner MUW, facilitated by the development of novel peptide reagents for manipulating autophagy which will be undertaken by undefinedPartner EMC.

 

    

Participants

 

Objectives of this work package

The research plan in this Work Package is designed to identify common pathways that influence disease outcome and response to treatment and infection in autoimmune and inflammatory diseases. 

>> WP2 - Identification of protein signatures

 

 

 

 

Search
Home
Menu
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

Albert Heck awarded highest scientific distinction in NL Read more

Social Media

TwitterLinkedIn